To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Knee osteoarthritis: Plasma rich in growth factor (Endoret) vs. hyaluronic acid (Durolane)

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2014

Knee osteoarthritis: Plasma rich in growth factor (Endoret) vs. hyaluronic acid (Durolane)

Vol: 3| Issue: 1| Number:36| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial

Arthroscopy. 2013 Oct;29(10):1635-43

Contributing Authors:
V Vaquerizo MA Plasencia I Arribas R Seijas S Padilla G Orive E Anitua

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

96 patients with osteoarthritis of the knee (OA) were randomized to evaluate the efficacy of 3 injections of plasma rich in growth factors (PRGF-Endoret) against a single injection of Durolane hyaluronic acid (HA) in treating knee OA. Treatments were primarily evaluated based on the percentage of patients having a 30% decrease and a 50% decrease in the summed score for all the Western Ontario and ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.